相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'
Guang Lin et al.
GENES & DEVELOPMENT (2011)
Trastuzumab resistance: all roads lead to SRC
Senthil K. Muthuswamy
NATURE MEDICINE (2011)
Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt
Minseong Kim et al.
FEBS LETTERS (2010)
Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells
Taichang Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dysregulation of the mevalonate pathway promotes transformation
James W. Clendening et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A human functional protein interaction network and its application to cancer data analysis
Guanming Wu et al.
GENOME BIOLOGY (2010)
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt
Przemyslaw Juszczynski et al.
BLOOD (2009)
被撤回的出版物: PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells (Retracted article. See vol. 293, pg. 3589, 2018)
Tasneem Motiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protein tyrosine phosphatase receptor type O regulates development and function of the sensory nervous system
Manuel R. Gonzalez-Brito et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Estrogen-Mediated Suppression of the Gene Encoding Protein Tyrosine Phosphatase PTPRO in Human Breast Cancer: Mechanism and Role in Tamoxifen Sensitivity
Bhuvaneswari Ramaswamy et al.
MOLECULAR ENDOCRINOLOGY (2009)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption
Shira Granot-Attas et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2008)
Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets
Katherine J. Martin et al.
PLOS ONE (2008)
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling
J-H Zhu et al.
ONCOGENE (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer
Mohamed Bentires-Alj et al.
CANCER RESEARCH (2007)
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
Sofi G. Julien et al.
NATURE GENETICS (2007)
Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation
Linfeng Chen et al.
BLOOD (2006)
Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O
Takafumi Shintani et al.
NATURE NEUROSCIENCE (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A novel substrate of receptor tyrosine phosphatase PTPRO is required for nerve growth factor-induced process outgrowth
B Chen et al.
JOURNAL OF NEUROSCIENCE (2005)
Modelling glandular epithelial cancers in three-dimensional cultures
J Debnath et al.
NATURE REVIEWS CANCER (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning
Y Mori et al.
CANCER RESEARCH (2004)
被撤回的出版物: Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer (Retracted article. See vol. 119, 2022)
T Motiwala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas
T Motiwala et al.
ONCOGENE (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Tyrosine phosphatase-ε activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells
H Gil-Henn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
The role of apoptosis in creating and maintaining luminal space with normal and oncogene-expressing mammary acini
J Debnath et al.
CELL (2002)
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
SK Muthuswamy et al.
NATURE CELL BIOLOGY (2001)
分享论文
